Abstract:Background: Transforming growth factor beta (TGF-β) is a multifunctional protein that acts as a regulator of cellular function such as proliferation, migration, differentiation, apoptosis, vascular hemostasis, and development of organisms. As the TGF-β is the key player of cell proliferation and apoptosis it also involves in different diseases such as autoimmune disorder and vascular disease. The TGF-β signaling pathway starts with the activation of TGFBRII and TGFBRI that trigger the phosphorylation of Smad cascade. The Smads complexes (Smad4+R-Smad) translocate to the nucleus and induce the transcription of the target gene. The dysregulation of the TGF-β signaling pathways has been reported in many human diseases including cancer. TGF-β acts as a tumor suppressor in the early stage of cancer but in late-stage show oncogenic factor and loss antiproliferative response. Objective: This reviews article determines the mechanism of TGF-β signaling pathways, the effect of TGF-β component on different cancers and provides a brief overview how it (TGF-β) acts as a tumor suppressor and promoter. Conclusion:TGF-β signaling pathways have a multifaceted and fundamental role in human development. It acts as a double-edged sword, both tumor suppressor, and tumor promoter. The tumor suppressor role is commonly designated as antiproliferative and apoptotic effects. TGF-β stops cell cycle at the G1 phase and promotes apoptosis. However, in advance stage of the tumor, it lost suppressor activities and begin tumor promotor due to the mutation in some component of the TGF-β pathway. Thus, The TGF-β can no longer control the cell cycle and proliferate the cancer cell. The increased production of TGF-β induces tumor invasion, motility, metastasis, immunosuppression epithelial-to-mesenchymal transition and angiogenesis. To study the exact molecular mechanism of TGF-β in the cancer cell and determine the oncogenic activities can provide successful and new therapeutic approach to reestablish the ordinary function of TGF-β. Keywords: Transforming growth factor beta, apoptosis, hemostasis, cancers, nucleus, carcinogenesis.

Role of Transforming Growth Factor-Beta Signaling Pathway in Pathogenesis of Benign Biliary Stricture.

Expression of transforming growth factor -β signalling pathway in the benign biliary stricture

Expressions and significance of TGF-β_1 and TβRⅠ in benign biliary stricture

Expression of CTGF in benign biliary stricture and its significance

Expression and Significance of TGF-β1 and COX-2 in Benign Biliary Stricture

Expression and significance of Smad4/Smad7 in benign biliary stricture

Expressions of Prostaglandin F2α Receptor and Cyclooxygenase-2 in Tissue of Benign Bile Duct Scar and Their Significances

Curcumin Inhibits Transforming Growth Factor-Beta Activity Via Inhibition of Smad Signaling in HK-2 Cells.

Mechanism of benign biliary stricture: a morphological and immunohistochemical study.

An Experimental Study on Mechanism of Benign Biliary Stricture

Nuclear factor KB and its inhibiting factor in the expression and significance in the process of benign biliary stricture formation

A Study on the Expressions and the Correlation of TGF-β 1 , and A-Sma in Healing Process of Bile Duct Trauma

THE EXPRESSION AND SIGNIFICANCE OF TRANSFORMING GROWTH FACTOR-β1 IN THE HEALING PROCESS OF BILE DUCT

The effect of TLR4/7 on the TGF-β-induced Smad signal transduction pathway in human keloid.

Clinical significance of the expression of transforming growth factor-β1 and connective tissue growth factor in detrusor of benign prostatic hyperplasia patients

The Expression of Smad4,TGF-β_1 and TβR II Protein in Cholangiocarcinoma

Local application of triamcinolone acetonide-conjugated chitosan membrane to prevent benign biliary stricture

Clinico-Pathological Importance of TGF-β/Phospho-Smad Signaling during Human Hepatic Fibrocarcinogenesis

Study on the expression of GSCs marker and it′s regulated factor in benign and malignant gallbladder lesions

The Expression of TGF-β1 in Tissues of Chronic Hepatitis B Patients

Positive and Negative Effects of TGF-β Signaling Pathways in Carcinogenesis